Retina Associates of Florida, LLC
Retina Associates of Florida, LLC
Tampa, Florida, United States6 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) | Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, age-related macular degeneration, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder, wet macular degeneration | Recruiting | Phase 2 / Phase 3 | 2026-10-02 | NCT07440225 | |
| Extension Study for the Port Delivery System With Ranibizumab (Portal) | Neovascular Age-Related Macular Degeneration | Recruiting | Phase 3 | 2026-09-28 | NCT03683251 | |
| Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR | Proliferative Diabetic Retinopathy (PDR) | Recruiting | Phase 3 | 2026-09-18 | NCT06790784 | |
| EC-104 Intravitreal Implant for the Treatment of Diabetic Macular Edema | diabetic macular edema | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-15 | NCT06536491 | |
| Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Visual Impairment, eye disorder, nervous system disorder, vision disorder | Recruiting | Phase 3 | 2026-08-20 | NCT05844982 | |
| Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD | Neovascular Age-related Macular Degeneration | Active, not recruiting | Phase 3 | 2026-07-07 | NCT05904028 |